Company Filing History:
Years Active: 2011
Title: Roger Åkerlund: Innovator in Fluid Transfer Technology
Introduction
Roger Åkerlund is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of fluid transfer systems. His innovative approach has led to the development of a unique device that enhances the efficiency and safety of infusion systems.
Latest Patents
Roger Åkerlund holds 1 patent for his invention titled "Method and device for fluid transfer in an infusion system." This patent describes a fluid transfer device designed for use in infusion systems. The device features a first end and a second end for coupling to an injection port of the infusion system. It includes at least a first member, a hollow needle attached to the first member, and a second member that is telescopically displaceable in relation to the first member. This design allows the hollow needle to penetrate a flexible barrier member sealing the injection port, thereby creating a fluid passage into the infusion system. The first end has a connecting portion for attachment to a drug bottle containing a fixed dose of a medical substance, while the second end has a flexible membrane that can be pressed against the flexible barrier member with sufficient pressure to create a double-membrane seal around the hollow needle.
Career Highlights
Roger Åkerlund is currently associated with Carmel Pharma AB, where he continues to innovate in the medical technology sector. His work focuses on improving infusion systems, which are critical in various medical treatments. His dedication to enhancing patient care through technology is evident in his patent and ongoing projects.
Collaborations
Roger collaborates with Kjell Andreasson, a fellow innovator in the field. Their combined expertise contributes to the advancement of medical technologies and the development of effective solutions for healthcare challenges.
Conclusion
Roger Åkerlund's contributions to fluid transfer technology exemplify the impact of innovation in the medical field. His patent and ongoing work at Carmel Pharma AB highlight his commitment to improving healthcare solutions.